AXA SA (CS.PA)

FR0000120628 - Common Stock

34.735  -0.19 (-0.53%)

Fundamental Rating

5

CS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 36 industry peers in the Insurance industry. Both the profitability and the financial health of CS get a neutral evaluation. Nothing too spectacular is happening here. CS is not valued too expensively and it also shows a decent growth rate. CS also has an excellent dividend rating.



5

1. Profitability

1.1 Basic Checks

CS had positive earnings in the past year.
In the past year CS had a positive cash flow from operations.
CS had positive earnings in each of the past 5 years.
Each year in the past 5 years CS had a positive operating cash flow.

1.2 Ratios

CS's Return On Assets of 1.09% is in line compared to the rest of the industry. CS outperforms 60.00% of its industry peers.
CS's Return On Equity of 14.13% is fine compared to the rest of the industry. CS outperforms 62.86% of its industry peers.
CS has a Return On Invested Capital of 1.21%. This is in the better half of the industry: CS outperforms 62.86% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CS is in line with the industry average of 2.00%.
Industry RankSector Rank
ROA 1.09%
ROE 14.13%
ROIC 1.21%
ROA(3y)1.01%
ROA(5y)0.77%
ROE(3y)12.73%
ROE(5y)9.51%
ROIC(3y)1.23%
ROIC(5y)1.01%

1.3 Margins

CS has a Profit Margin (8.23%) which is comparable to the rest of the industry.
CS's Profit Margin has improved in the last couple of years.
CS has a Operating Margin (11.15%) which is comparable to the rest of the industry.
CS's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.15%
PM (TTM) 8.23%
GM N/A
OM growth 3Y23.76%
OM growth 5Y4.76%
PM growth 3Y46.22%
PM growth 5Y36.38%
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CS is destroying value.
The number of shares outstanding for CS has been increased compared to 1 year ago.
CS has less shares outstanding than it did 5 years ago.
CS has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.33, we must say that CS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CS (0.33) is better than 94.29% of its industry peers.
CS has a debt to FCF ratio of 3.74. This is a good value and a sign of high solvency as CS would need 3.74 years to pay back of all of its debts.
CS has a Debt to FCF ratio (3.74) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.49 indicates that CS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.49, CS is in line with its industry, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 3.74
Altman-Z 0.33
ROIC/WACC0.12
WACC10.07%

2.3 Liquidity

CS has a Current Ratio of 0.99. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
CS has a better Current ratio (0.99) than 82.86% of its industry peers.
CS has a Quick Ratio of 0.99. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.99, CS belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.27% over the past year.
Measured over the past years, CS shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.03% on average per year.
The Revenue for CS has decreased by -15.52% in the past year. This is quite bad
The Revenue has been decreasing by -4.60% on average over the past years.
EPS 1Y (TTM)15.27%
EPS 3Y35.79%
EPS 5Y32.03%
EPS growth Q2Q34.3%
Revenue 1Y (TTM)-15.52%
Revenue growth 3Y-9.14%
Revenue growth 5Y-4.6%
Revenue growth Q2Q-23.49%

3.2 Future

The Earnings Per Share is expected to grow by 6.58% on average over the next years.
The Revenue is expected to grow by 0.89% on average over the next years.
EPS Next Y6.5%
EPS Next 2Y7.56%
EPS Next 3Y10.07%
EPS Next 5Y6.58%
Revenue Next Year-2.14%
Revenue Next 2Y1.08%
Revenue Next 3Y0.89%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.13 indicates a reasonable valuation of CS.
Compared to the rest of the industry, the Price/Earnings ratio of CS is on the same level as its industry peers.
When comparing the Price/Earnings ratio of CS to the average of the S&P500 Index (25.20), we can say CS is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 9.60, the valuation of CS can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CS indicates a slightly more expensive valuation: CS is more expensive than 60.00% of the companies listed in the same industry.
CS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.60.
Industry RankSector Rank
PE 11.13
Fwd PE 9.6

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as CS.
Industry RankSector Rank
P/FCF 11.81
EV/EBITDA N/A

4.3 Compensation for Growth

CS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.71
PEG (5Y)0.35
EPS Next 2Y7.56%
EPS Next 3Y10.07%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.85%, CS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.28, CS pays a bit more dividend than its industry peers.
CS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 5.85%

5.2 History

The dividend of CS has a limited annual growth rate of 3.81%.
Dividend Growth(5Y)3.81%
Div Incr Years3
Div Non Decr Years3

5.3 Sustainability

CS pays out 56.37% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of CS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP56.37%
EPS Next 2Y7.56%
EPS Next 3Y10.07%

AXA SA

EPA:CS (4/24/2024, 9:35:15 AM)

34.735

-0.19 (-0.53%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap77.33B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 5.85%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 11.13
Fwd PE 9.6
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.71
PEG (5Y)0.35
Profitability
Industry RankSector Rank
ROA 1.09%
ROE 14.13%
ROCE
ROIC
ROICexc
ROICexgc
OM 11.15%
PM (TTM) 8.23%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)15.27%
EPS 3Y35.79%
EPS 5Y
EPS growth Q2Q
EPS Next Y6.5%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-15.52%
Revenue growth 3Y-9.14%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y